Metadherin expression is associated with proliferative and metastasizing properties in triple-negative BC, according to Liu et al.22, while Tokunaga et al.7 indicated that Metadherin was expressed at low levels in patients with BC and high ER and/or PR expression. The gene discussed is ESR1; the disease is breast cancer.